iRxReminder Announces Enrollment of Initial Patients in Groundbreaking Tardive Dyskinesia Detection Study

iRxReminder, LLC, a pioneer in medical adherence technology, is thrilled to announce the enrollment of its first patients in the innovative NIMH-funded study.

Share this news:

Twitter/X LinkedIn

More News

Press Release October 17, 2025

Videra Health Named to MountainWest Capital Network's 2025 Utah 100 Emerging Elite

Product Launch September 23, 2025

Videra Health Launches "Check on Mom," the First Free AI-Powered Postpartum Depression Screener

Press Release July 13, 2025

5 Things You Should Know About Tardive Dyskinesia

Want to learn more?

See how Videra Health is transforming behavioral healthcare with AI.

Explore the Platform